StockNews.com began coverage on shares of Agenus (NASDAQ:AGEN – Get Rating) in a research report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other analysts have also commented on AGEN. HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of Agenus […]